$ARKG monthly flipping the important 0.236 log Fibonacci level from resistance to support. This is a rather high-risk ETF as ARKG holds mostly small to mid cap genomics and biotech firms. Doesn't look like a risk-off period is starting if an ETF like that starts looking
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
$ARKG monthly flipping the important 0.236 log Fibonacci level from resistance to support. This is a rather high-risk ETF as ARKG holds mostly small to mid cap genomics and biotech firms. Doesn't look like a risk-off period is starting if an ETF like that starts looking